You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):公司有銷售部分醫美相關產品,整體佔比較小
格隆匯 06-19 17:51

格隆匯6月19日丨有投資者於投資者互動平台向重藥控股(000950.SZ)提問,“最近一段時間中藥材全面暴升,請問公司是否有中藥飲片和中藥材種植基地,公司醫美肉毒素現在怎麼樣了,能滿足醫美市場的需要嗎?”

公司回覆稱,公司目前的中藥業務主要以配送為主,另外公司控股子公司重慶醫藥集團杭州醫藥有限公司,是一家中藥飲片生產企業,該飲片廠引進了目前國內外先進的中藥飲片生產檢驗設備40多台/套,達到了可年產5000噸常規中藥飲片生產線,可生產中藥常規中藥飲片300餘種,目前處於試生產階段。公司有銷售部分醫美相關產品,整體佔比較小。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account